We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current APTO market cap is 3.11M. The company's latest EPS is USD -2.8276 and P/E is -23.55.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -14.1M | -14.45M | -11.68M | -9.76M | -7.35M |
| Net Income | -13.68M | -14.13M | -11.45M | -9.64M | -7.25M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -26.86M | -55.77M | -65.45M | -42.6M | -52.36M |
| Net Income | -26.28M | -55.24M | -65.35M | -41.82M | -51.21M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 39.33M | 26.58M | 20.88M | 12.8M | 10.95M |
| Total Liabilities | 13.34M | 12.79M | 13.1M | 12.66M | 13.13M |
| Total Equity | 25.99M | 13.79M | 7.78M | 137k | -2.18M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 100.48M | 126.26M | 82.53M | 51.03M | 12.99M |
| Total Liabilities | 6.55M | 7.35M | 8.29M | 13.29M | 15.89M |
| Total Equity | 93.93M | 118.92M | 74.24M | 37.74M | -2.9M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -11.3M | -13.5M | -10.54M | -11.76M | -5.78M |
| Investing | -2.96M | -1.96M | 12.95M | -1.99M | 2.01M |
| Financing | 50k | 1.1M | 4.9M | 11.85M | 4.75M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -21.56M | -33.89M | -43.3M | -32.32M | -44.59M |
| Investing | -17.37M | 12.63M | -35.21M | 30.07M | 9.96M |
| Financing | 103.45M | 58.81M | 226k | 116k | 6.91M |
| Market Cap | 3.11M |
| Price to Earnings Ratio | -23.55 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 130.36 |
| Price to Book Ratio | -415.75 |
| Dividend Yield | - |
| Shares Outstanding | 18.11M |
| Average Volume (1 week) | 546.59k |
| Average Volume (1 Month) | 182.05k |
| 52 Week Change | -93.38% |
| 52 Week High | 2.9077 |
| 52 Week Low | 0.159 |
| Spread (Intraday) | 0.01 (5.56%) |
| Company Name | Aptose Biosciences Inc |
| Address |
5955 airport road mississauga, ontario L4V 1R9 |
| Website | https://www.aptose.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
